The U.S. Food and Drug Administration has cleared for marketing a device that a doctor can use to see inside a blood vessel to assess the fat content of the plaque which builds up on the wall of the ...
Medical Device Network on MSN
Coronary plaque reimbursement presages CAD care evolution
Plaque analysis is now formally recognised, widely accepted, and reimbursable by insurers in the US, including Medicare.
Coronary stents were first developed in the mid 1980s, revolutionizing coronary artery disease treatment for patients. While stents are still used in patients today, only incremental developments in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results